i also think the IF will take time to gain traction in markets as a new product, like every other new profuct, and will need some heavy discounting to encourage market share as well as promotional campaigns
its a medium term play
would only think bal m&a is a good play if cheap
- Forums
- ASX - By Stock
- BKL
- the new under the oldrse
the new under the oldrse, page-82
-
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BKL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online